The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: European markets uneasy but FTSE 100 outperforms

Tue, 17th Oct 2023 12:06

(Alliance News) - London's FTSE 100 higher was higher around midday, though it was defensive stocks such as utilities and pharmaceuticals which led the charge, suggesting there is still lingering discomfort in markets amid tensions in the Middle East.

Easing some UK interest rate worries, numbers showed pay growth eased, possibly taking some pressure off the Bank of England ahead of its decision next month. The pound was on the back foot, however.

The FTSE 100 index added 32.51 points, 0.4%, at 7,663.14. The FTSE 250 was up 55.39 points, 0.3%, at 17,574.78, and the AIM All-Share was down 0.61 of a point, 0.1%, at 686.20.

The Cboe UK 100 was up 0.4% at 765.39, the Cboe UK 250 was up 0.5% at 15,274.60, and the Cboe Small Companies added 0.2% at 12,821.77.

"Helping to give UK stocks a boost were the latest figures on jobs, with a slowdown in wage growth. That in theory reduces the chances of the Bank of England rushing to put up interest rates again," AJ Bell analyst Russ Mould commented.

According to the Office for National Statistics, in the three months to August, annual growth in average total pay, excluding bonuses, was 7.8%.

This was in line with market consensus, as cited by FXStreet. The figure for the previous three-month period was revised upwards to 7.9% from 7.8%.

Including bonuses, average pay growth cooled to 8.1%, which undershot market expectations of 8.3%. It was 8.5% in the three months to July. The data including bonuses were affected by the one-off payments made in June through August to NHS and civil service staff, the ONS noted.

Analysts at ING commented: "While wage growth is still much too strong for the Bank of England's liking, there's nothing in the latest data that's likely to push the committee into a rate hike at the November meeting."

"Admittedly, this is an unusually thinned-down jobs report, with many of the key numbers, including unemployment, delayed for a week due to quality concerns. Those numbers, when we get them, will still have some bearing on the Bank's next decision, but committee members have made it abundantly clear that private-sector regular pay growth is the key metric it's watching - and that number has been released today as planned."

UK unemployment data, which is customarily released alongside the pay data, comes next week.

Sterling was quoted at USD1.2154 early Tuesday afternoon, lower than USD1.2194 at the London equities close on Monday. The euro was little changed at USD1.0549 compared to USD1.0548. Against the yen, the dollar was quoted at JPY149.58, largely flat against JPY149.56.

In European equities on Tuesday, the CAC 40 in Paris was down 0.2% and the DAX 40 in Frankfurt was 0.4% lower.

Still to come in the economic calendar, there is a US retail sales reading at 1330 BST.

Ahead of the data, stocks in New York are called lower. The Dow Jones Industrial Average is called down 0.2%, the S&P 500 also down 0.2% and the Nasdaq Composite 0.3% lower.

Focus is also on the US earnings calendar, with Goldman Sachs reporting third-quarter results shortly.

Bank of America was up 0.2% in pre-market dealings in New York. It said total revenue in the third-quarter edged up 2.7% to USD25.17 billion from USD24.50 billion. Net income increased 10% to USD7.80 billion from USD7.08 billion.

In London, Rolls-Royce rose 0.8%, as it announced it is set to axe between 2,000 to 2,500 jobs as part of a cost-cutting plan, driven by its new chief executive. The company confirmed a report from Sky News, which on Monday said the aircraft engine manufacturer based in Derby is expected to announce plans to lay off around 2,500 staff as soon as Tuesday.

Rolls Royce explained: "The new structure will create a more agile business that is better able to serve customers and continue to create and maintain world-class products. It will help Rolls-Royce build enhanced capabilities in key areas such as procurement and supply chain management, ensuring they are as strong as the company's engineering and technical excellence."

The cuts aim to eliminate duplication and cut costs, it explained, noting it employs 42,000 people worldwide.

Sky had reported that the cuts will be distributed across its global operations and are likely to affect hundreds of UK staff, citing people close to the situation. Tufan Erginbilgic, who took over as Rolls-Royce's chief executive at the start of the year, said the firm is "building a Rolls-Royce that is fit for the future".

Melrose Industries added 0.7%. It talked up its Engines business, as the FTSE 100 constituent is confident in meeting its 2025 targets.

The company said it "can now confirm" that the Engines arm's adjusted operating margin will continue to outperform against previous guidance.

Melrose now expects a full-year 2023 margin of around 24%, instead of the 22% forecast in mid-May.

"Melrose has full confidence that the 2025 targets will be achieved and current trading makes that more secure," the FTSE 100 company said on Tuesday. It added that the "biggest single reason" for the outperformance was continued strong aftermarket demand at high margins.

The firm recently sharpened its focus on the aerospace sector following its demerger of Dowlais, which is composed of Melrose's former GKN Automotive, GKN Powder Metallurgy and GKN Hydrogen businesses.

Also on the up, water utilities Severn Trent, United Utilities and Pennon added 2.4%, 3.3% and 2.6%. Sentiment towards the sector improved after business plans, which outlined investment plans in the year to come, were well-received.

Investor sentiment towards water utilities had been muted leading up to the announcements earlier in October, amid regulatory worries and woes at peer Thames Water.

It was a generally stronger day for more defensive stocks. Drugmaker AstraZeneca rose 2.1%, British Gas owner Centrica climbed 1.0% and consumer goods maker Unilever rose 1.1%.

Digital 9 Infrastructure jumped 12% as it said it has retained Goldman Sachs International as a financial adviser to support the development of "a set of actions focused on maximising shareholder value".

It said the move followed a consultation with shareholders after some had given feedback about the company's dividend policy and "future direction".

In late-September, the firm withdrew its dividend target.

Digital 9 is managed by Triple Point Investment Management and invests in assets such as data centres, subsea fibre cables, and mobile phone masts.

Elsewhere in London, THG rose 5.8%. It said its third-quarter was its best quarterly revenue performance in the year-to-date. Third-quarter revenue declined "year-on-year", however.

In the three months that ended September 30, the Manchester-based e-commerce firm said revenue fell 4.4% to GBP466.5 million, or 2.1% on a constant currency basis, from a year earlier. Revenue in the year-to-date fell 5.5% to GBP1.42 billion, or 5.7% on a constant currency basis.

THG said its full-year revenue guidance of a flat outcome to 5% fall from a year earlier remains unchanged.

"[The third quarter] has been another strong quarter of progress across the group, with each division delivering improved performances. The pivots made within each division to ensure they thrive in a high inflation global environment are bearing fruit. The momentum with which we exited [the third quarter] was especially pleasing, with the group returning to positive constant currency revenue growth of 3.2% in September, driven by a strong performance across our Beauty division," said Chief Executive Officer Matthew Moulding.

Gold was quoted at USD1,924.02 an ounce early Tuesday afternoon, up from USD1,921.22 on Monday. Brent oil was trading at USD89.93 a barrel, lower than USD90.19.

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.